Brief: Paradigm Biopharmaceuticals Signs Binding Veterinary Licensing & Supply Agreement
09/02/2026 01:42
Feb 9 (Reuters) - Paradigm Biopharmaceuticals Ltd PAR.AX: SIGNS BINDING VETERINARY LICENSING & SUPPLY AGREEMENT FOR ORAL PPS + COX-2 INHIBITOR COMBINATION CO ELIGIBLE TO RECEIVE UP TO A$1 MILLION FROM AVET IN DEVELOPMENT MILESTONES Further company coverage: PAR.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Paradigm Biopharmaceuticals
See all newsBrief: Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration
Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
Australia's Paradigm Biopharmaceuticals slips on discounted placement
Brief: Paradigm Biopharmaceuticals Says Co Completes A$14 Mln Placement
Brief: Paradigm Biopharmaceuticals Requests Trading Halt